South Dakota Investment Council Boosts Stock Holdings in Teleflex Incorporated (NYSE:TFX)

South Dakota Investment Council increased its stake in Teleflex Incorporated (NYSE:TFX) by 18.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 5,835 shares of the medical technology company’s stock after acquiring an additional 900 shares during the period. South Dakota Investment Council’s holdings in Teleflex were worth $1,455,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently modified their holdings of the company. LGT Capital Partners LTD. raised its position in Teleflex by 285.4% during the 4th quarter. LGT Capital Partners LTD. now owns 257,864 shares of the medical technology company’s stock valued at $64,296,000 after purchasing an additional 190,950 shares during the last quarter. Invesco Ltd. increased its holdings in shares of Teleflex by 23.3% during the third quarter. Invesco Ltd. now owns 621,445 shares of the medical technology company’s stock valued at $122,058,000 after acquiring an additional 117,401 shares in the last quarter. Adage Capital Partners GP L.L.C. bought a new position in shares of Teleflex during the third quarter valued at $9,173,000. Cooke & Bieler LP increased its holdings in shares of Teleflex by 5.7% during the fourth quarter. Cooke & Bieler LP now owns 734,965 shares of the medical technology company’s stock valued at $183,256,000 after acquiring an additional 39,308 shares in the last quarter. Finally, Boston Trust Walden Corp increased its holdings in shares of Teleflex by 17.6% during the fourth quarter. Boston Trust Walden Corp now owns 227,888 shares of the medical technology company’s stock valued at $56,822,000 after acquiring an additional 34,100 shares in the last quarter. Institutional investors own 95.62% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on TFX shares. JMP Securities restated a “market outperform” rating and set a $285.00 price target on shares of Teleflex in a report on Friday, February 23rd. StockNews.com downgraded Teleflex from a “buy” rating to a “hold” rating in a report on Friday, February 23rd. Truist Financial reduced their price objective on Teleflex from $270.00 to $265.00 and set a “hold” rating for the company in a report on Friday, February 23rd. Finally, Royal Bank of Canada reduced their price objective on Teleflex from $272.00 to $265.00 and set an “outperform” rating for the company in a report on Friday, February 23rd. Five analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $267.50.

Insider Activity

In related news, VP Cameron P. Hicks sold 7,401 shares of the business’s stock in a transaction that occurred on Tuesday, March 5th. The stock was sold at an average price of $225.00, for a total value of $1,665,225.00. Following the transaction, the vice president now directly owns 10,050 shares of the company’s stock, valued at approximately $2,261,250. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Insiders own 1.43% of the company’s stock.

Teleflex Trading Up 0.0 %

Teleflex stock opened at $211.17 on Thursday. The business has a 50-day simple moving average of $223.09 and a two-hundred day simple moving average of $225.66. The company has a market cap of $9.95 billion, a P/E ratio of 28.04, a P/E/G ratio of 2.02 and a beta of 1.11. Teleflex Incorporated has a 52-week low of $177.63 and a 52-week high of $276.43. The company has a quick ratio of 1.29, a current ratio of 2.32 and a debt-to-equity ratio of 0.39.

Teleflex (NYSE:TFX) last released its quarterly earnings results on Thursday, February 22nd. The medical technology company reported $3.38 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.26 by $0.12. Teleflex had a return on equity of 14.98% and a net margin of 11.98%. The business had revenue of $773.90 million during the quarter, compared to the consensus estimate of $769.01 million. During the same period in the previous year, the company posted $3.52 EPS. The business’s quarterly revenue was up 2.1% compared to the same quarter last year. Analysts predict that Teleflex Incorporated will post 13.73 EPS for the current year.

Teleflex Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 15th. Stockholders of record on Friday, March 1st were given a dividend of $0.34 per share. The ex-dividend date of this dividend was Thursday, February 29th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.64%. Teleflex’s payout ratio is currently 18.06%.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.